Company Monitoring Page for BeiGene

latest headlines for company on cafepharma

Bristol Myers Squibb is nixing BeiGene's Abraxane deal in China amid manufacturing woes. Is their cancer rivalry really to blame?
Fierce Pharma
Thu, 10/14/21 - 11:09 am
Tags:
cancer, Bristol Myers Squibbe, BeiGene, Abraxane, China, drug manufacturing
FDA grants BeiGene's Brukinsa accelerated approval in marginal zone lymphoma
Seeking Alpha
Wed, 09/15/21 - 11:00 am
Tags:
BeiGene, Brukinsa, FDA, accelerated approvals, marginal zone lymphoma
First FDA filing for Novartis’ latecomer PD-1 drug tislelizumab
Pharmaforum
Mon, 09/13/21 - 10:26 am
Tags:
Novartis, tiselizumab, FDA, esophageal cancer, BeiGene
FDA approves BeiGene's Brukinsa in rare blood cancer amid company's US expansion plans
Endpoints
Thu, 09/2/21 - 10:29 am
Tags:
BeiGene, Brukinsa, blood cancer, FDA
Life Sciences Companies Expand Their Footprints in the US and Canada
BioSpace
Thu, 08/19/21 - 12:02 am
Tags:
life sciences, United States, Canada, Rentschler Biopharma, Moderna Therapeutics, Precision NanoSystems, BeiGene, Aro Biotherapeutics, Evotec
BeiGene tees up 3-way leukemia competition against J&J-AbbVie, AstraZeneca with Brukinsa win
Fierce Pharma
Mon, 08/2/21 - 10:57 am
Tags:
BeiGene, Brukinsa, CLL, small lymphocytic lymphoma, clinical trials
Five Collaborations Unlocking Faster Drug Development this Week
BioSpace
Thu, 06/10/21 - 11:12 am
Tags:
drug development, MannKind, Thirona Bio, pulmonary fibrosis, Oyster Point Pharma, Adaptive Phage Therapeutics, ophthalmic, Takeda, Codexis, ALX Oncology, Eli Lilly, clinical trials, BeiGene, Shoreline Biosciences, oncology
BeiGene dives in on natural killer cells with discovery pact for small biotech's stem cell-based platform
Endpoints
Wed, 06/9/21 - 11:09 am
Tags:
BeiGene, China, natural killer cells, cell therapy, Shoreline Biosciences
BeiGene’s Tislelizumab Improves Survival in Esophageal Cancer Study
BioSpace
Thu, 01/28/21 - 11:10 pm
Tags:
BeiGene, monoclonal antibodies, tislelizumab, clinical trials, esophageal cancer
BeiGene, Novartis in pact to develop tislelizumab for cancer settings
Seeking Alpha
Mon, 01/11/21 - 06:56 pm
Tags:
Novartis, BeiGene, tiselizumab, cancer, drug development
ASH: AstraZeneca's Calquence, BeiGene's Brukinsa turn heads with new data, putting Imbruvica on notice
Fierce Pharma
Sun, 12/6/20 - 07:15 pm
Tags:
AstraZeneca, BeiGene, JNJ, AbbVie, Calquence, Brukinsa, Imbruvica, CLL, ASH2020
$200M investment to advance clinical programs for Ambrx
MedCity News
Mon, 11/23/20 - 10:18 pm
Tags:
Ambrx, oncology, Astellas, BeiGene, Bristol-Myers Squibb
BeiGene beefs up PD-1 data with positive PhIII results for tislelizumab, this time in metastatic NSCLC
Endpoints
Tue, 11/17/20 - 11:00 am
Tags:
BeiGene, metastatic non-small cell lung cancer
Esmo 2020 – some backing for Beigene’s unusual combo approach
EP Vantage
Mon, 09/21/20 - 10:26 am
Tags:
ESMO, BeiGene, urothelial cancer
BeiGene, Singlomics sign licencing agreement on neutralising Covid-19 antibodies
Pharmaceutical Business Review
Fri, 08/28/20 - 10:26 am
Tags:
BeiGene, SInglomics, COVID-19
BeiGene expands pipeline and hops on board a quest to cure hep B, inking a $540M deal with a fellow upstart biotech
Endpoints
Mon, 07/20/20 - 10:29 am
Tags:
China, BeiGene, Assembly Biosciences, hepatitis B
Chinese Biotech Beigene to Raise $2.1 Billion in Share Sale
Bloomberg
Mon, 07/13/20 - 11:07 am
Tags:
China, BeiGene, Amgen, NASDAQ
Important catalysts approach for smaller biotechs
EP Vantage
Wed, 06/24/20 - 10:35 am
Tags:
BeiGene, Turning Point Therapeutics, Intra-Cellular Therapies, Immunovant, Caplyta, Brukinsa, repotrectinib, IMVT-1401, clinical trials
BeiGene reports positive Phase III interim analysis for lung cancer drug
MedCity News
Wed, 04/15/20 - 10:41 am
Tags:
BeiGene, clinical trials, immunotherapy, lung cancer, tislelizumab, non-squamous non-small cell lung cancer
BeiGene’s Tislelizumab Could Challenge Merck’s Keytruda in the Checkpoint Inhibitor Market
BioSpace
Thu, 01/23/20 - 12:22 pm
Tags:
BeiGene, tiselizumab, non-small cell lung cancer, Merck, Keytruda

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.